First Header Logo Second Header Logo

Connection

Michael Zapadka to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Michael Zapadka has written about Xenograft Model Antitumor Assays.
Michael Zapadka
Connection Strength
0.026
Xenograft Model Antitumor Assays
  1. Krishnan B, Smith TL, Dubey P, Zapadka ME, Torti FM, Willingham MC, Tallant EA, Gallagher PE. Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis. Prostate. 2013 Jan; 73(1):71-82.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.